FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
- PDF / 10,930,633 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 66 Downloads / 211 Views
ORIGINAL RESEARCH ARTICLE
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma Koos Koole1,2 • Martijn J. A. M. Clausen3,4 • Robert J. J. van Es2 • Pauline M. W. van Kempen5 • Lieuwe J. Melchers4 • Ron Koole2 • Johannes A. Langendijk6 • Paul J. van Diest1 • Jan L. N. Roodenburg4 Ed Schuuring3 • Stefan M. Willems1,7
•
Ó The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Introduction Fibroblast growth factor receptor family member proteins (FGFR1–4) have been identified as promising novel therapeutic targets and prognostic markers in a wide spectrum of solid tumors. The present study investigates the expression and prognostic value of four FGFR family member proteins in a large multicenter oral cavity squamous cell carcinoma (OCSCC) and oropharyngeal squamous cell carcinoma (OPSCC) cohort. Methods Protein expression of FGFR1–4 was determined by immunohistochemistry on tissue microarrays containing 951 formalin-fixed paraffin embedded OCSCC and OPSCC tissues from the University Medical Center Utrecht and University Medical Center Groningen. Protein expression was correlated to overall survival using Cox regression models, and bootstrapping was performed as internal validation. Results FGFR proteins were highly expressed in 39–64 % of OCSCC and 63–79 % of OPSCC. Seventy-three percent (299/412) of OCSCC and 85 % (305/357) of OPSCC highly co-expressed two or more FGFR family member
proteins. FGFR1 protein was more frequently highly expressed in human papillomavirus (HPV)-negative OPSCC than HPV-positive OPSCC (82 vs. 65 %; p = 0.008). Furthermore, protein expression of FGFR family members was not related to overall survival in OCSCC or OPSCC (p [ 0.05). Conclusion FGFR family members are frequently highly expressed in OCSCC and OPSCC. These FGFR family member proteins are therefore potential targets for novel therapies that are urgently required to improve survival of OCSCC and OPSCC patients. Key Points FGFR family members have been identified as novel therapeutic targets and prognostic markers in multiple types of cancer. In this study we found high expression of all four FGFR family member proteins in large oral cavity and oropharyngeal squamous cell carcinoma cohorts. All four FGFR family member proteins may serve as potential therapeutic targets.
Electronic supplementary material The online version of this article (doi:10.1007/s40291-016-0204-5) contains supplementary material, which is available to authorized users. & Stefan M. Willems [email protected]
4
Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
1
Department of Pathology, University Medical Center Utrecht, H4.2.41, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
5
Department of Otorhinolaryngology–Head and Neck Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
2
Department
Data Loading...
